Butyrate as a promising therapeutic target in cancer: From pathogenesis to clinic

J Sun, S Chen, D Zang, H Sun… - … journal of oncology, 2024 - spandidos-publications.com
Cancer is one of the leading causes of mortality worldwide. The etiology of cancer has not
been fully elucidated yet, and further enhancements are necessary to optimize therapeutic …

Crosstalk between miRNA and PI3K/AKT/mTOR signaling pathway in cancer

M Akbarzadeh, A Mihanfar, S Akbarzadeh, B Yousefi… - Life Sciences, 2021 - Elsevier
Abstract Phosphoinositide-3 kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR)
signaling pathway is one of the most important proliferative signaling pathways with critical …

PI3K/Akt signaling in osteosarcoma

J Zhang, XH Yu, YG Yan, C Wang, WJ Wang - Clinica chimica acta, 2015 - Elsevier
Osteosarcoma (OS) is the most common nonhematologic bone malignancy in children and
adolescents. Despite the advances of adjuvant chemotherapy and significant improvement …

Role of SCFAs in gut microbiome and glycolysis for colorectal cancer therapy

G Wang, Y Yu, YZ Wang, JJ Wang… - Journal of cellular …, 2019 - Wiley Online Library
Increased risk of colorectal cancer (CRC) is associated with altered intestinal microbiota as
well as short‐chain fatty acids (SCFAs) reduction of output The energy source of colon cells …

Short-chain fatty acids in cancer pathogenesis

MA Feitelson, A Arzumanyan, A Medhat… - Cancer and Metastasis …, 2023 - Springer
Cancer is a multi-step process that can be viewed as a cellular and immunological shift
away from homeostasis in response to selected infectious agents, mutations, diet, and …

miR-143-3p inhibits the proliferation, migration and invasion in osteosarcoma by targeting FOSL2

X Sun, G Dai, L Yu, Q Hu, J Chen, W Guo - Scientific reports, 2018 - nature.com
Osteosarcoma (OS) is the most common type of primary malignant bone tumor and mainly
occurs in children and adolescent. Because of its early migration and invasion, OS has a …

Metabolic reprogramming and potential therapeutic targets in lymphoma

Y Pang, T Lu, ZY Xu-Monette, KH Young - International Journal of …, 2023 - mdpi.com
Lymphoma is a heterogeneous group of diseases that often require their metabolism
program to fulfill the demand of cell proliferation. Features of metabolism in lymphoma cells …

Implications of miR cluster 143/145 as universal anti-oncomiRs and their dysregulation during tumorigenesis

AV Das, RM Pillai - Cancer cell international, 2015 - Springer
Tumorigenesis is a multistep process, de-regulated due to the imbalance of oncogenes as
well as anti-oncogenes, resulting in disruption of tissue homeostasis. In many cases the …

Polycomb genes, miRNA, and their deregulation in B-cell malignancies

GG Wang, KD Konze, J Tao - … Journal of the American Society of …, 2015 - ashpublications.org
Posttranslational modifications of histone proteins represent a fundamental means to define
distinctive epigenetic states and regulate gene expression during development and …

[HTML][HTML] Pre-clinical activity of targeting the PI3K/Akt/mTOR pathway in Burkitt lymphoma

M Bhatti, T Ippolito, C Mavis, J Gu, MS Cairo, MS Lim… - Oncotarget, 2018 - ncbi.nlm.nih.gov
Though outcomes for pediatric Burkitt lymphoma (BL) have improved significantly in recent
decades with intensive multi-agent chemotherapy and the addition of rituximab …